FOLH1 and prostate adenocarcinoma: A study from 2022 reported that prostate-specific membrane antigen (PSA), expressed in the prostate epithelium that is upregulated in prostate adenocarcinoma, was expressed in 98,9% of meningioma specimens within their endothelial cells (Tubre et al., 2022).